BeOne Medicines Ltd. (NASDAQ: ONC) announced that data from its HERIZON-GEA-01 phase 3 clinical trial were published in The New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE